Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications.

Zhiming ZhaoXiaomo LiFei WangYong XuSi LiuQuanli HanZhiying YangWeiwei HuangZhuzeng YinQu LiuHaidong TanTonghui MaShuang SiJia HuangHongling YuanWei LiJianhua Liu

Published in: Cancer medicine (2023)

Our results demonstrated that a genetic screen of actionable genomic variants could facilitate precision therapy and cancer risk reduction in pancreatic cancer patients of Asian ethnicity.

Keyphrases

copy number
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
genome wide
peritoneal dialysis
gene expression
dna methylation
stem cells
patient reported outcomes
cell therapy
single cell
smoking cessation